(135) demonstrated that metformin mixed with sorafenib promoted iron apoptosis via the p62-Keap1-Nrf2/HO1 signaling pathway, inhibiting the value-added of HCC cells. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.